
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145871510.1021/acsomega.8b00067ArticleI2-Catalyzed Oxidative Cross-Coupling
Reaction of Methyl Ketones and 2-(2-Aminophenyl) Benzimidazole:
Facile Access to Benzimidazo[1,2-c]quinazoline Ambethkar Sethurajan Kalaiselvi Mariappan Ramamoorthy Jaganathan Padmini Vediappen *Department of Organic Chemistry,
School of Chemistry, Madurai Kamaraj University, Madurai 625021, Tamil Nadu, India* E-mail: padmini.chem@mkuniversity.org, padimini_tamilenthi@yahoo.co.in.08 05 2018 31 05 2018 3 5 5021 5028 24 01 2018 23 03 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A general
and efficient iodine-catalyzed metal-free oxidative cross-coupling
reaction of methyl ketones with 2-(1H-benzo[d]imidazol-2-yl)aniline has been established. This is a
new synthetic strategy for the synthesis of benzimidazo[1,2-c]quinazoline derivatives involving C(sp3)–H
oxidation, condensation, and cyclization processes.

document-id-old-9ao8b00067document-id-new-14ao-2018-00067accc-price
==== Body
Introduction
The
direct oxidative C–H bond functionalization has emerged
as an effective tool for the construction of carbon–carbon
and carbon–heteroatom bonds.1 Transition
metals play vital role in oxidative C–H coupling reactions.2 Metal-free organic syntheses for the construction
of C–C and C–X bonds are also popular.3 Molecular iodine is a popular catalyst in various organic
transformations owing to its easy availability and inexpensive, nontoxic,
eco-friendly, and nonmetallic nature.4 Additionally,
molecular iodine has superfluous advantages as it has the lowest dissociation
energy, no radioactivity, and a moderate redox potential.5 In 2010, Li et al. reported I2-mediated
oxidative cyclization of enamines via iodide intermediates.6

Nitrogen-containing heterocycles are ubiquitous
scaffolds in numerous
natural products, biomolecules, and organic materials.7 Benzo[4,5]imidazo[1,2-c]quinazoline is
a trinitrogen heterocycle that hosts both the fused structure of benzimidazole
and quinazoline via a shared bond.8 The
combination of benzimidazole and quinazoline frameworks, benzimidazoquinazoline
derivatives, are valuable substrates with different biological activities
as shown in Figure 1 and benzoimidazo[1,2-c]quinazoline derivatives
exhibit wide spectrum of therapeutic activities such as antimicrobial,9 antitumor,10 anticancer,11 antiviral,12 anti-inflammatory,13 and anticonvulsants.14 Due to the remarkable importance of these molecules, we planned
to propose a new method for construction of benzoimidazo[1,2-c]quinazoline derivatives. A number of synthetic methodologies
for construction of the compounds containing this core structure were
reported. Hulme et al.15 reported a cesium
carbonate-promoted three-component reaction, CuI-catalyzed Ullmann
N-arylation.16 Fu et al. reported a copper-catalyzed
cascade synthesis of benzimidazoquinazoline derivatives under mild
conditions (Scheme 1a).17 Fu et al. developed a general method
for the synthesis of benzoimidazo[1,2-c] quinazolines
via copper-catalyzed reactions of substituted 2-(2-halophenyl)-1H-benzo[d]imidazoles with α-amino
acids (Scheme 1b).18 Later, Koutentis and co-workers reported Cu-
and Pd-catalyzed oxidative and nonoxidative C–N coupling reactions
to give the corresponding products in high yields (Scheme 1c).19 Recently, Sarada et al. established a nickel-catalyzed aerobic oxidative
isocyanide insertion reaction for the synthesis of a novel benzimidazoquinazolines
via sequential double annulation cascade protocol (Schemes 1d and 2).20 All of the
above reports suffer from drawbacks such as the use of prefunctionalized
starting materials, harsh reaction conditions, longer reaction time,
and metal catalyst. Therefore, the development of new approaches to
the synthesis of benzimidazoquinazolines using simpler and more readily
available starting materials under milder conditions is still highly
desirable.

Figure 1 Biologically important benzoimidazo[1,2-c]quinazolines.

Scheme 1 Recent Approaches for the Construction
of Benzoimidazo[1, 2-c]quinazolines
Scheme 2 Synthesis of Benzoimidazo Quinazolinones
In continuation of our ongoing
research to develope new routes
for the construction of various heterocyclic systems,21 we investigated the reaction of 4-methylacetophenone 1b with 2-(1H-benzo[d]imidazol-2-yl)
aniline 2 as model substrates for the present study.
The reaction has been carried out under various reaction conditions,
as depicted in Table 1. On treatment of 1b with 2 and an equivalent
of iodine as the catalyst in N,N-dimethylacetamide (DMA) at 110 °C for 6 h, the desired product 3b was not formed (Table 1, entry 1). Further optimization was done by the use
of other common organic solvents including N,N-dimethylformamide (DMF), toluene, N-methylpyrrolidone
(NMP), acetonitrile, and DMSO (Table 1, entries 2–6), and DMSO has been proved to
be the best solvent. Next, we tried the reaction in the absence of
the catalyst in dimethyl sulfoxide (DMSO), but there was no product
obtained even after long reaction time. Hence, additional optimization
experiments were performed in the presence of various iodides such
KI, NIS, TBAI, and NH4I in DMSO at 110 °C for 6 h.
However, the desired product was not obtained (Table 1, entries 8–11). Further increase
in the amount of iodine did not lead to significant differences in
the yield (Table 1,
entry 12). Further, we optimized the reaction in the presence of different
stoichiometric amounts of iodine in DMSO (Table 1, entries 13–17), the corresponding
product was obtained in 78, 80, 83, and 75% yield, respectively. The
combination of iodine (20 mol %) and DMSO was found to be efficient
for this transformation (Table 1, entry 16). So, all of the reactions were carried out under
this reaction conditions.

Table 1 Optimization of Reaction
Conditionsa
entry	catalyst (equiv)	solvent	temp	yield (%)b	
1	I2 (1.0)	DMAc	110 °C	NR	
2	I2 (1.0)	DMFc	110 °C	NR	
3	I2 (1.0)	toluene	110 °C	NR	
4	I2 (1.0)	NMPc	reflux	NR	
5	I2 (1.0)	CH3CN	reflux	NR	
6	I2 (1.0)	DMSOc	110 °C	78	
7	−	DMSOc	110 °C	NR	
8	KI (1.0)	DMSO	110 °C	NR	
9	NIS (1.0)	DMSOc	110 °C	NR	
10	TBAI (1.0)	DMSOc	110 °C	NR	
11	NH4I (1.0)	DMSOc	110 °C	NR	
12	I2 (1.2)	DMSOc	110 °C	73	
13	I2 (0.8)	DMSOc	110 °C	78	
14	I2 (0.6)	DMSOc	110 °C	80	
15	I2 (0.4)	DMSOc	110 °C	80	
16	I2 (0.2)	DMSOc	110 °C	83	
17	I2 (0.1)	DMSOc	110 °C	75	
a Reaction conditions: 1b (1.0 equiv) additive and solvent (2 mL) are heated in a sealed tube
at 110 °C for 6 h and then 2 (1.0 equiv) is added.

b Yield of the isolated product.

c DMF = N,N-dimethylformamide,
DMA = N,N-dimethylacetamide, NMP
= N-methylpyrrolidone, DMSO
= dimethyl sulfoxide.

With
the optimized reaction conditions in hand, we then investigated
the substrate scope of the aryl methyl ketones, as shown in Scheme 3. Aryl methyl ketones
bearing electron-donating and electron-withdrawing substituents were
successfully converted directly into the corresponding products in
moderate to good yields (73–83%; 3a–3h). Moreover, sterically hindered acetyl naphthalene has
only little influence on the reaction efficiency (73–83%; 3j and 3k). Notably, heterocyclic methyl ketones
also participated in the reaction affording the corresponding products 3n–3p in 59–62% yields, respectively.

Scheme 3 Substrate Scope of the Transformation,
Reaction conditions: 1 (1.0 equiv), 2 (1.0 equiv), and I2 (0.2
equiv) in DMSO (2 mL) at 110 °C.

Isolated yield.

To have a better
understanding of the reaction mechanism, a series
of control experiments were performed (Scheme 4). The reaction of acetophenone 1a with 2 in presence of I2 affords 3a in good yields (Scheme 4a). Next, the reaction was carried out α-iodoketone 1ab with DMSO and phenylglyoxal was obtained in 81% yield
(Scheme 4b). Subsequently,
the reaction of α-iodoketone 1ab with 2-(1H-benzo[d]imidazol-2-yl) aniline 2 was found to be effective and the product 3a was obtained in 69% yield (Scheme 4c). When the acetophenone was replaced with phenylglyoxal 1ac, the desired product was obtained in 75% yield (Scheme 4d). These results
confirmed that α-iodoketone 1ab is a possible precursor
of α-ketoaldehyde 1ac. Moreover, the results also
indicated that phenacyl iodide 1ab and phenylglyoxal 1ac are the key intermediates in the transformation. Finally,
the radical trapping experiments were tested (Scheme 4e). 2,2,6,6-Tetramethylpiperidinyloxy (TEMPO)
was used as a radical scavenger. In the presence of TEMPO, desired
product was observed in good yield (71%) and this result shows that
radical intermediates were not involved in this reaction.

Scheme 4 Investigation
Into the Reaction Mechanism
Structural elucidation of benzoimidazoquinazoline was
accomplished
by using one-dimensional and two-dimensional, as described for 3b. In the 1H NMR spectrum (see the SI) of 3b, the methyl protons appear
as a sharp singlet at 2.43 ppm, which gives C–H COSY correlation
with the carbon at 22.5 ppm and β-hydroxy β-methylbutyrate
(HMB) correlation with the carbons at 130.2 and 145.7 ppm (Figure 2). The two-proton
signal appears as a doublet at 8.09 ppm (J = 7.8
Hz), which gives C–H COSY correlation with the carbon at 130.2
ppm and HMB correlation with the carbons at 145.7 and 191.9 ppm.

Figure 2 1H, 13C chemical shifts and HMB correlations
of 3b.

The structure of the
product 3 was confirmed by an
electrospray ionization mass spectroscopy (ESI-MS). On the basis of
the above results and literature reports, a plausible mechanism for
the formation of 3 is shown in Scheme 5.5b First, the
reaction of 1 with I2 results in the formation
of α-iodoketone 1ab. Subsequently, oxidation of 1ab with DMSO at 110 °C gives arylglyoxal 1ac, with the removal of dimethyl sulfide. The next step is the reaction
between arylglyoxal 1ac and 2 that generates
an iminium ion intermediate 2a. The intermediate 2a is quickly converted to the desired product 3.

Scheme 5 Plausible Mechanism for the Formation of Benzoimidazoquinazoline
Derivatives
Conclusions
We
have developed a simple, novel, and efficient method for the
synthesis of benzoimidazoquinazoline by iodine-catalyzed oxidative
C–H amination of aryl methyl ketones and 2-(1H-benzo[d]imidazol-2-yl) aniline. The initial studies
of the mechanism suggest that this reaction could have occurred through
a self-sequenced iodination/Kornblum oxidation/C–H amination
and intramolecular cyclization reactions.

General Methods
The melting points were measured in
open capillary tubes and were uncorrected. The 1H and 13C NMR spectra were recorded on a Bruker (Avance) 300 MHz
NMR instrument using TMS as internal standard either CDCl3 or DMSO-d6 as solvent. Chemical shifts
are given in parts per million (δ-scale) and the coupling constants
are given in hertz (Hz). Silica gel-G plates (Merck) were used for
thin layer chromatography (TLC) analysis with a mixture of petroleum
ether (60–80 °C) and ethyl acetate as eluent. High-resolution
mass spectra were recorded on a Waters Q-TOF micromass spectrometer
using ESI mode.

General Experimental Procedure for 3 Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(phenyl)methanone
(3a–3n)
A mixture of aryl
methyl ketone 1 (100 mg, 0.83 mmol) and 2-(1H-benzo[d]imidazol-2-yl) aniline 2 (174
mg, 0.83 mmol) was taken
in a 10 mL round-bottom flask in DMSO and 2 mL of I2 (42
mg, 20 mol %) was added and reaction mixture was refluxed at 110 °C
for 6 h. The reaction was monitored by TLC using n-hexane/ethyl acetate mixture (3:2) as eluent. After the completion
of the reaction, the mixture was poured into ice water, worked up
with sodium thiosulphate, and extracted with ethyl acetate. The organic
layer was collected, dried on anhydrous sodium sulfate, and the solvent
was evaporated on a rotary evaporator to get the crude product. The
crude product was purified by silica gel column using 30:70 n-hexane/ethyl acetate.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(phenyl)methanone
(3a)
Yellow solid (215 mg, 80%); mp 222–224
°C; 1H NMR (300 MHz, DMSO-d6) δ 8.18 (d, J = 7.9 Hz, 1H), 8.03 (d, J = 7.7 Hz, 2H), 7.80 (d, J = 7.8 Hz, 1H),
7.61 (d, J = 7.1 Hz, 1H), 7.56–7.44 (m, 2H),
7.29–7.14 (m, 3H), 7.00 (s, 1H), 6.93 (t, J = 7.1 Hz, 1H), 6.76 (d, J = 8.1 Hz, 1H), 6.28 (s,
1H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 190.1, 147.4, 143.0, 140.0, 133.2,
132.1, 130.6, 128.1, 127.4, 124.1, 121.6, 118.7, 118.0, 115.0, 112.3,
108.2.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(p-tolyl)methanone (3b)
Yellow solid
(209 mg, 83%); mp 226–228 °C; 1H NMR (300 MHz,
DMSO-d6) δ 8.13 (d, J = 7.5 Hz, 1H), 7.91 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 7.8 Hz, 1H), 7.28–7.19 (m, 3H), 7.16–7.10
(m, 2H), 6.99 (d, J = 7.7 Hz, 1H), 6.88 (dd, J = 9.8, 5.1 Hz, 1H), 6.74 (d, J = 7.9
Hz, 1H), 6.52 (d, J = 3.4 Hz, 1H), 2.39 (s, 3H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 191.9, 149.0, 145.8, 144.7, 142.1, 134.0, 132.2,
131.2, 130.4, 130.2, 125.4, 123.1, 122.9, 119.7, 119.5, 116.2, 113.8,
110.5, 22.1; HRMS (m/z) (ESI): calcd
for C22H15N3O 337.1215; found 337.1219
[M + H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(4-methoxyphenyl)methanone
(3c)
Yellow solid (191 mg, 81%); mp 194–196
°C; 1H NMR (300 MHz, DMSO-d6) δ 8.11 (d, J = 8.8 Hz, 2H), 8.06 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 7.8 Hz, 1H),
7.35 (d, J = 3.5 Hz, 1H), 7.29–7.12 (m, 5H),
7.00 (d, J = 8.8 Hz, 2H), 6.83 (dd, J = 15.2, 7.8 Hz, 2H), 3.87 (s, 3H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 189.3,
164.0, 148.2, 143.8, 141.1, 132.9, 131.4, 131.2, 125.6, 124.7, 122.4,
122.2, 119.1, 118.7, 115.4, 114.1, 112.9, 108.9, 55.5; HRMS (m/z) (ESI): calcd for C22H15N3O2 353.1164; found 353.1169 [M +
H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(3-methoxyphenyl)methanone
(3d)
Yellow solid (188 mg, 80%); mp 183–185
°C; 1H NMR (300 MHz, DMSO-d6) δ 8.16 (d, J = 7.6 Hz, 1H), 7.89 (d, J = 3.7 Hz, 1H), 7.78 (d, J = 7.8 Hz, 2H),
7.70 (d, J = 4.9 Hz, 1H), 7.29–7.18 (m, 5H),
7.15–7.08 (m, 1H), 6.96–6.87 (m, 2H), 6.85–6.70
(m, 3H) 3.86 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 188.4, 163.1, 147.2, 142.9, 140.2, 132.0, 130.5, 130.3,
124.7, 123.8, 121.5, 121.3, 118.2, 117.8, 114.5, 113.2, 112.0, 108.0,
54.5.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(4-hydroxyphenyl)methanone
(3e)
Yellow solid (194 mg, 78%); mp 188–190
°C; 1H NMR (300 MHz, DMSO-d6) δ 10.38 (s, 1H), 8.07–8.00 (m, 2H), 7.75–7.70
(m, 1H), 7.25–7.15 (m, 5H), 6.94 (d, J = 8.7
Hz, 2H), 6.84 (dd, J = 15.9, 7.5 Hz, 2H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 188.3, 162.4, 147.3, 143.0, 140.5, 132.2, 130.8,
130.4, 123.9, 123.6, 121.5, 121.4, 118.2, 117.9, 115.0, 114.6, 112.2,
108.1.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(3,4-methoxyphenyl)methanone
(3f)
Yellow solid (159 mg, 75%); mp 189–191
°C; 1H NMR (300 MHz, CDCl3 with DMSO-d6) δ 8.03 (d, J = 7.1
Hz, 1H), 7.93 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 7.9 Hz, 1H), 7.54 (s, 1H), 7.43 (broad, s, 1H), 7.35
(d, J = 7.8 Hz, 1H), 7.23–7.12 (m, 3H), 7.05
(d, J = 8.5 Hz, 1H), 6.83 (t, J =
7.4 Hz, 2H), 3.93 (s, 3H), 3.85 (s, 3H); 13C NMR (75 MHz,
CDCl3 with DMSO-d6) δ
188.4, 152.7, 147.7, 147.0, 142.5, 140.1, 131.7, 130.0, 124.4, 123.4,
122.9, 121.1, 120.9, 117.6, 117.4, 114.1, 111.5, 109.9, 109.5, 108.0,
54.7, 54.5 HRMS (m/z) (ESI): calcd
for C23H17N3O3 383.1270;
found 383.1274 [M + H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(4-chlorophenyl)methanone
(3g)
Yellow solid (151 mg, 71%); mp 198–200
°C; 1H NMR (300 MHz, CDCl3) δ 8.10
(d, J = 7.5 Hz, 1H), 7.96 (d, J =
8.4 Hz, 2H), 7.75 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H), 7.24–7.18 (m, 5H), 6.88 (t, J = 7.5 Hz, 1H), 6.80 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 189.4, 147.4, 143.4,
140.0, 132.3, 131.4, 131.2, 130.8, 130.0, 124.4, 122.0, 121.9, 119.2,
118.4, 115.3, 112.7, 108.1; HRMS (m/z) (ESI): calcd for C21H12ClN3O 357.0669;
found 357.0676 [M + H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(4-bromophenyl)methanone
(3h)
Yellow solid (144 mg, 72%); mp 200–202
°C; 1H NMR (300 MHz, CDCl3 with DMSO-d6) δ 8.14 (d, J = 7.8
Hz, 1H), 7.92 (d, J = 8.6 Hz, 2H), 7.77 (d, J = 7.8 Hz, 1H), 7.60 (d, J = 8.5 Hz, 2H),
7.22 (ddd, J = 17.1, 10.6, 4.2 Hz, 4H), 7.01 (d, J = 4.3 Hz, 1H), 6.90 (dd, J = 9.2, 5.8
Hz, 2H), 6.79 (d, J = 7.9 Hz, 1H); 13C
NMR (75 MHz, CDCl3 with DMSO-d6) δ 190.5, 148.2, 144.4, 140.8, 133.3, 132.5, 132.2, 131.8,
130.9, 129.6, 125.6, 123.1, 123.0, 120.5, 119.6, 116.3, 113.8, 109.0;
HRMS (m/z) (ESI): calcd for C21H12BrN3O 401.0164; found: 401.0172
[M + H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(3,4-dichlorophenyl)methanone
(3i)
Yellow solid (140 mg, 68%); mp 192–194
°C; 1H NMR (300 MHz, CDCl3 with DMSO-d6) δ 8.28 (d, J = 1.8
Hz, 1H), 8.09 (d, J = 7.8 Hz, 1H), 7.95 (dd, J = 8.4, 1.9 Hz, 1H), 7.75 (d, J = 7.8
Hz, 1H), 7.58 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 4.5 Hz, 1H), 7.29–7.17 (m, 4H), 6.92–6.77
(m, 2H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 194.3, 153.3, 149.2, 145.7, 143.4,
138.3, 138.1, 133.6, 130.3, 127.9, 127.8, 125.2, 124.3, 121.3, 118.8,
114.2; HRMS (m/z) (ESI): calcd for
C21H11Cl2N3O 391.0279;
found: 391.0279 [M+].

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(naphthalen-2-yl)methanone
(3j)
Yellow solid (138 mg, 63%); mp 186–188
°C; 1H NMR (300 MHz, DMSO-d6) δ 8.25 (d, J = 8.1 Hz, 1H), 8.19–8.00
(m, 3H), 7.90 (d, J = 8.5 Hz, 2H), 7.78 (d, J = 7.5 Hz, 1H), 7.66–7.47 (m, 3H), 7.38–7.27
(m, 1H), 7.22 (dd, J = 17.7, 10.8 Hz, 2H), 7.07–6.93
(m, 1H), 6.82–6.14 (m, 1H), 6.63 (d, J = 8.4
Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 194.6, 143.3, 141.0, 132.9, 132.6, 131.5, 131.3, 130.8,
129.8, 128.0, 127.3, 126.0, 125.3, 124.7, 124.2, 124.0, 123.4, 122.3,
121.8, 121.6, 118.9, 118.5, 118.1, 115.6, 114.8, 112.5, 109.3. HRMS
(m/z) (ESI): calcd for C25H15N3O 373.1215; found: 373.1216 [M + H]+.

[1,1′-Biphenyl]-4-yl(benzo[4,5]imidazo[1,2-c]quinazolin-6-yl)methanone (3k)
Yellow
solid
(136 mg, 65%); mp 230–232 °C; 1H NMR (300 MHz,
CDCl3) δ 8.21 (d, J = 8.1 Hz, 2H),
8.09 (d, J = 7.0 Hz, 1H), 7.75 (dd, J = 7.4, 2.9 Hz, 3H), 7.65 (d, J = 6.8 Hz, 2H), 7.54–7.38
(m, 5H), 7.35–7.28 (m, 2H), 7.27–7.15 (m, 3H), 6.86
(dd, J = 15.5, 7.8 Hz, 2H). 13C NMR (75
MHz, CDCl3 with DMSO-d6) δ
195.7, 153.5, 151.5, 149.3, 146.3, 144.4, 138.4, 137.1, 136.6, 135.0,
134.2, 133.7, 132.5, 132.3, 130.2, 127.8, 127.7, 124.7, 124.2, 121.0,
118.5, 114.3; HRMS (m/z) (ESI):
calcd for C27H17N3NaO 422.1269; found:
422.1471 [M + Na]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(5-bromothiophen-2-yl)methanone
(3l)
Yellow solid (116 mg, 58%); mp 218–220
°C; 1H NMR (300 MHz, DMSO-d6) δ 8.14 (d, J = 6.8 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 7.53 (d, J = 4.1 Hz, 1H),
7.30–7.17 (m, 4H), 7.02 (d, J = 4.1 Hz, 1H),
6.93 (t, J = 7.5 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 6.63 (t, J = 4.0 Hz, 2H).13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 185.1, 144.3, 140.7, 140.5, 134.5, 133.4, 132.9,
132.8, 125.6, 123.7, 120.1, 119.8, 116.3, 113.4, 109.3.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(furan-2-yl)methanone
(3m)
Yellow solid (165 mg, 56%); mp 194–196
°C; 1H NMR (300 MHz, CDCl3 with DMSO-d6) δ 8.06 (d, J = 7.2
Hz, 1H), 7.85–7.83 (m, 1H), 7.73 (d, J = 7.2
Hz, 1H), 7.32–7.19 (m, 5H), 6.99 (m, 3H), 6.68 (s, 1H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 179.7, 148.3, 147.4, 146.9, 143.1, 140.4, 132.1,
130.5, 123.9, 121.7, 121.6, 119.6, 118.4, 118.1, 114.5, 112.0, 108.1;
HRMS (m/z) (ESI): calcd for C19H11N3O2 313.0851; found
313.0862 [M + H]+.

Benzo[4,5]imidazo[1,2-c]quinazolin-6-yl(pyridin-3-yl)methanone
(3n)
Yellow solid (139 mg, 52%); mp 224–226
°C; 1H NMR (300 MHz, CDCl3 with DMSO-d6) δ 8.61 (d, J = 27.0
Hz, 2H), 8.13 (s, 1H), 7.67 (d, J = 51.6 Hz, 3H),
7.24 (s, 4 H), 6.87 (s, 5H); 13C NMR (75 MHz, CDCl3 with DMSO-d6) δ 185.8,
155.7, 153.0, 152.6, 149.3, 147.5, 140.5, 139.2, 137.9, 136.9, 130.4,
129.0, 127.8, 127.7, 124.5, 124.4, 120.4, 117.8, 115.0. HRMS (m/z) (ESI): calcd for C20H12N4O 324.1011; found 324.1016 [M + H]+.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b00067.Typical procedure
and characterization data for benzimidazo[1,2-c]quinazoline
and NMR and HRMS spectra of all synthesized
compounds (PDF)



Supplementary Material
ao8b00067_si_001.pdf

 The
authors
declare no competing financial interest.

Acknowledgments
We thank
DST, New Delhi, for assistance under the IRHPA program
for the NMR facility. S.A. gratefully acknowledges UGC, New Delhi,
for the award of RGNF Fellowship.
==== Refs
References
a Shi W. ; Liu C. ; Lei A. 
Transition-metal
catalyzed
oxidative cross-coupling reactions to form C-C bonds involving organometallic
reagents as nucleophiles . Chem. Soc. Rev. 
2011 , 40 , 2761 –2776 . 10.1039/c0cs00125b .21283847  b He C. ; Guo S. ; Ke J. ; Hao J. ; Xu H. ; Chen H. Y. ; Lei A. 
Silver-Mediated Oxidative C–H/C–H Functionalization:
A Strategy To Construct Polysubstituted Furans . J. Am. Chem. Soc. 
2012 , 134 , 5766 –5769 . 10.1021/ja301153k .22428614  c Fiori K. W. ; DuBois J. 
Catalytic Intermolecular Amination
of C–H Bonds: Method Development and Mechanistic Insights . J. Am. Chem. Soc. 
2007 , 129 , 562 –568 . 10.1021/ja0650450 .17227019  d Kim M. ; Mulcahy J. V. ; Espino C. G. ; DuBois J. 
Expanding
the substrate scope for C-H amination reactions: oxidative cyclization
of urea and guanidine derivatives . Org. Lett. 
2006 , 8 , 1073 –1076 . 10.1021/ol052920y .16524271  e Liang C. G. ; Robert-Peillard F. ; Fruit C. ; Müller P. ; Dodd R. H. ; Dauban P. 
You have full text access to this
content Efficient Diastereoselective Intermolecular Rhodium-Catalyzed
C[BOND]H Amination . Angew. Chem., Int. Ed. 
2006 , 45 , 4641 –4644 . 10.1002/anie.200601248 .
a Park Y. ; Kim Y. ; Chang S. 
Transition
Metal-Catalyzed
C–H Amination: Scope, Mechanism, and Applications . Chem. Rev. 
2017 , 117 , 9247 –9301 . 10.1021/acs.chemrev.6b00644 .28051855  b Meng D. ; Tang Y. ; Wei J. ; Shia X. Y. ; Yang M. 
Copper-catalyzed remote (δ) C(sp3)–H bond
amination: a practical strategy to construct pyrrolidine derivatives . Chem. Commun. 
2017 , 53 , 5744 –5747 . 10.1039/C7CC02624B . c Evans R. W. ; Zbieg J. R. ; Zhu S. L. ; Li W. ; MacMillan D. W. C. 
Simple Catalytic Mechanism for the
Direct Coupling of α-Carbonyls with Functionalized Amines: A
One-Step Synthesis of Plavix . J. Am. Chem. Soc. 
2013 , 135 , 16074 –16077 . 10.1021/ja4096472 .24107144  d Rong G. ; Mao J. ; Yan H. ; Zheng Y. ; Zhang G. 
Iron/Copper Co-Catalyzed
Synthesis of Vinyl Sulfones from Sulfonyl Hydrazides and Alkyne Derivatives . J. Org. Chem. 
2015 , 80 , 4697 –4703 . 10.1021/acs.joc.5b00558 .25876519  e Nadres E. T. ; Daugulis O. 
Heterocycle
Synthesis via Direct C–H/N–H Coupling . J. Am. Chem. Soc. 
2012 , 134 , 7 –10 . 10.1021/ja210959p .22206416  f Yang M. ; Su B. ; Wang Y. ; Chen K. ; Jiang X. ; Zhang Y. F. ; Zhang X. S. ; Chen G. ; Cheng Y. ; Cao Z. ; Guo Q. ; Wang L. ; Shi Z. J. 
Silver-catalysed direct amination of unactivated C-H
bonds of functionalized molecules . Nat. Commun. 
2014 , 5 , 470710.1038/ncomms5707 .25140832  g Sengoden M. ; Bhowmick A. ; Punniyamurthy T. 
Stereospecific Copper-Catalyzed Domino
Ring Opening and sp3 C–H Functionalization of Activated
Aziridines with N-Alkylanilines . Org. Lett. 
2017 , 19 , 158 –161 . 10.1021/acs.orglett.6b03458 .27977211 
a Yan R. ; Li X. ; Yang X. ; Kang X. ; Xiang L. ; Huang G. 
A novel one-pot method
for the synthesis
of substituted furopyridines: iodine-mediated oxidation of enaminones
by tandem metal-free cyclization . Chem. Commun. 
2015 , 51 , 2573 –2576 . 10.1039/C4CC08834D . b Finkbeiner P. ; Nachtsheim B. J. 
Iodine in Modern Oxidation Catalysis . Synthesis 
2013 , 979 –999 . 10.1055/s-0032-1318330 . c Bagdi A. K. ; Mitra S. ; Ghosh M. ; Hajra A. 
Iodine-catalyzed
regioselective thiolation of imidazo[1,2-a]pyridines using sulfonyl
hydrazides as a thiol surrogate . Org. Biomol.
Chem. 
2015 , 13 , 3314 –3320 . 10.1039/C5OB00033E .25644749  d Liu S. ; Xi H. ; Zhang J. ; Wu X. ; Gao Q. ; Wu A. 
Organopromoted direct synthesis of 6-iodo-3-methylthioimidazo[1,2-a]pyridines
via convergent integration of three self-sorting domino sequences . Org. Biomol. Chem. 
2015 , 13 , 8807 –8811 . 10.1039/C5OB01313E .26214059  e Wu Y. D. ; Geng X. ; Gao Q. ; Zhang J. J. ; Wu X. ; Wu A. 
Iodine-promoted sequential
dual oxidative Csp3–H amination/Csp3–H
iodination reactions: efficient synthesis of 1-iodoimidazo[1,5-a]pyridines . Org. Chem. Front. 
2016 , 3 , 1430 –1434 . 10.1039/C6QO00313C .
a Song L. ; Tian X. ; Lv Z. ; Li E. ; Wu J. ; Liu Y. ; Yu W. ; Chang J. 
I2/KI-Mediated Oxidative
N–N Bond Formation for the Synthesis of 1,5-Fused 1,2,4-Triazoles
from N-Aryl Amidines . J. Org. Chem. 
2015 , 80 , 7219 –7225 . 10.1021/acs.joc.5b01183 .26114202  b Ren Y. M. ; Cai C. ; Yang R. C. 
Molecular iodine-catalyzed multicomponent reactions:
an efficient catalyst for organic synthesis . RSC Adv. 
2013 , 3 , 7182 –7204 . 10.1039/c3ra23461d . c Togo H. ; Iida S. 
Synthetic Use of Molecular Iodine
for Organic Synthesis . Synlett 
2006 , 2159 –2175 . 10.1055/s-2006-950405 . d Parvatkar P. T. ; Parameswaran P. S. ; Tilve S. G. 
Recent Developments in the Synthesis
of Five- and Six-Membered Heterocycles Using Molecular Iodine . Chem. - Eur. J. 
2012 , 18 , 5460 –5489 . 10.1002/chem.201100324 .22488798 
a Gao Q. ; Zhang J. J. ; Wu X. ; Liu S. ; Wu A. X. 
Direct
Regioselective Oxidative Cross-Coupling of Indoles with Methyl
Ketones: A Novel Route to C3-Dicarbonylation of Indoles . Org. Lett. 
2015 , 17 , 134 –137 . 10.1021/ol503366r .25494534  b Zhang Z. ; Xie C. ; Tan X. ; Song G. ; Wen L. ; Gao H. ; Ma C. 
I2-Catalyzed one-pot synthesis
of pyrrolo[1,2-a]quinoxaline and imidazo[1,5-a]quinoxaline derivatives
via sp3 and sp2 C–H cross-dehydrogenative
coupling . Org. Chem. Front. 
2015 , 2 , 942 –946 . 10.1039/C5QO00124B . c Küpper F. C. ; Feiters M. C. ; Olofsson B. ; Kaiho T. ; Yanagida S. ; Zimmermann M. B. ; Carpenter L. J. ; Luther G. W. III; Lu Z. L. ; Jonsson M. ; Kloo L. 
Commemorating two centuries
of iodine research: an interdisciplinary overview of current research . Angew. Chem., Int. Ed. 
2011 , 50 , 11598 –11620 . 10.1002/anie.201100028 .
a He Z. H. ; Li H. R. ; Li Z. P. 
Iodine-Mediated
Synthesis of 3H-Indoles via Intramolecular Cyclization of Enamines . J. Org. Chem. 
2010 , 75 , 4636 –4639 . 10.1021/jo100796s .20524670  b He Z. ; Liu W. P. ; Li Z. P. 
I2-Catalyzed Indole Formation via Oxidative Cyclization of N-Aryl Enamines . Chem. Asian J. 
2011 , 6 , 1340 –1343 . 10.1002/asia.201100045 .21506283 
a Kattrizky A. R. ; Pozharskii A. F.  Handbook
of Heterocyclic Chemistry ; Pergamon, 2 nd ed.; Academic Press : Amsterdam , 2000 , pp 1 –760 .b Li J. J.  Heterocyclic Chemistry in Drug Discovery ; John Wiley & Sons, Inc. : Hoboken , 2013 .
von
Niementowski S. 
Ueber neue Arten der Anhydroverbindungen . Ber. Dtsch. Chem. Ges. 
1899 , 32 , 1456 –1493 . 10.1002/cber.18990320223 .
a Habib O. M. O. ; Hassan H. M. ; El-Mekabaty A. 
Novel quinazolinone
derivatives: synthesis and antimicrobial activity . Med. Chem. Res. 
2013 , 22 , 507 –519 . 10.1007/s00044-012-0079-x . b Kuarm B. S. ; Reddy Y. T. ; Madhav J. V. ; Crooks P. A. ; Rajitha B. 
3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones
as potent antimicrobial agents . Bioorg. Med.
Chem. Lett. 
2011 , 21 , 524 –527 . 10.1016/j.bmcl.2010.10.082 .21134751  c Rohini R. ; Shanker K. ; Muralidhar R. ; Ravinder V. 
Synthesis and antimicrobial activities of a new class
of 6-arylbenzimidazo[1,2-c]quinazolines . J.
Braz. Chem. Soc. 
2010 , 21 , 49 –57 . 10.1590/S0103-50532010000100009 . d Rohini R. ; Shanker K. ; Reddy P. M. ; Ho Y. P. ; Ravinder V. 
Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines:
A new class of antimicrobial agents . Eur. J.
Med. Chem. 
2009 , 44 , 3330 –3339 . 10.1016/j.ejmech.2009.03.022 .19371978 
a Braña M. F. ; de Vega M. J. P. ; Perron D. ; Conlon D. ; Bousquet P. F. ; Robinson S. P. 
Benzimidazo[1,2-c]quinazoline
dimers as potential antitumor agents . J. Heterocycl.
Chem. 
1997 , 34 , 807 –812 . 10.1002/jhet.5570340316 . b Braña M. F. ; Castellano J. M. ; Keilhauer G. ; Machuca A. ; Martín Y. ; Redondo C. ; Schlick E. ; Walker N. 
Benzimidazo[1,2-c]quinazolines:
a new class of antitumor compounds . Anticancer
Drug Des. 
1994 , 9 , 527 –538 .7880377 
a Lamazzi C. ; Lé once S. ; Pfeiffer B. ; Renard P. ; Guillaumet G. ; Rees C. W. ; Besson T. 
Expeditious synthesis and cytotoxic
activity of new cyanoindolo[3,2-c]quinolines and benzimidazo[1,2-c]quinazolines . Bioorg. Med. Chem. Lett. 
2000 , 10 , 2183 –2185 . 10.1016/S0960-894X(00)00427-3 .11012025  b Via L. D. ; Gia O. ; Mango S. M. ; Settimo A. D. ; Marini A. M. ; Primofiore G. ; Settimo F. D. A. ; Salerno S. 
Synthesis,
in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline
derivatives as potential anti-tumor agents . Farmaco 
2001 , 56 , 159 –167 . 10.1016/S0014-827X(01)01079-5 .11409322  c Lunn W. H. W. ; Harper R. W. ; Stone R. L. 
Benzimidazo[2,1-b]quinazolin-12-ones.
New class of potent immunosuppressive compounds . J. Med. Chem. 
1971 , 14 , 1069 –1071 . 10.1021/jm00293a012 .5115206 
a Kozlowski J. A. ; Rosenblum S. B. ; Coburn C. A. ; Shankar B. B. ; Anilkumar G. N. ; Chen L. ; Dwyer M. P. ; Jiang Y. ; Keertikar K. M. ; Lavey B. J. ; Selyutin O. B. ; Tong L. ; Wong M. ; Yang D.
Y. ; Yu W. ; Zhou G. ; Wu H. ; Hu B. ; Zhong B. ; Sun F. ; Ji T. ; Shen C.  Tetracyclic Indole Derivatives
and Methods of Use Thereof for the Treatment of Viral Diseases , WO2012040923 , April 5, 2012 .b Lyakhova E.
A. ; Gusyeva Y. A. ; Nekhoroshkova J. V. ; Shafran L. M. ; Lyakhov S. A. 
Synthesis and affinity
to DNA of phenylbenzoimidazoles and benzoimidazo[1,2-c]quinazolines . Eur. J. Med. Chem. 
2009 , 44 , 3305 –3312 . 10.1016/j.ejmech.2009.03.004 .19349097 
Galarce G. D. ; Foncea R. E. ; Edwards A. M. ; Pessoa-mahana H. ; Mahana C. D. P. ; Ebensperger R. A. 
Biological evaluation of novel 6-Arylbenzimidazo[1,2-c]quinazoline
derivatives as inhibitors of LPS-induced TNF-alpha secretion . Biol. Res. 
2008 , 41 , 43 –50 . 10.4067/S0716-97602008000100006 .18769762 
Wolfe J. F. ; Rathman T. L. ; Sleevi M. C. ; Campbell J. A. ; Greenwood T. D. 
Synthesis
and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones . J. Med. Chem. 
1990 , 33 , 161 10.1021/jm00163a027 .2296016 
Martinez-Ariza G. ; McConnell N. ; Hulme C. 
One-Pot Two-Step Multicomponent Process
of Indole and Other Nitrogenous Heterocycles or Amines toward α-Oxo-acetamidines . Org. Lett. 
2016 , 18 , 1864 –1867 . 10.1021/acs.orglett.6b00634 .27020621 
Pang X. ; Chen C. ; Li M. ; Xi C. 
A concise and efficient
synthesis of benzimidazo[1,2-c]quinazolines through CuI-catalyzed
intramolecular N-arylations . Beilstein J. Org.
Chem. 
2015 , 11 , 2365 –2369 . 10.3762/bjoc.11.258 .26734086 
Xu S. ; Lu J. ; Fu H. 
Copper-catalyzed
cascade synthesis of benzimidazoquinazoline
derivatives under mild condition . Chem. Commun. 
2011 , 47 , 5596 –5598 . 10.1039/c1cc10383k .
Liu Q. ; Yang H. ; Jiang Y. ; Zhao Y. ; Fu H. 
Efficient
copper-catalyzed domino synthesis of tetrazoloisoquinolines . RSC Adv. 
2013 , 3 , 15636 –15644 . 10.1039/c3ra41644e .
Mirallai S. I. ; Koutentis P. A. 
The Conversion
of 4-Anilinoquinazoline- and 3-Aryl-4-imino-3,4dihydro-quinazoline-2-carbonitriles
into Benzo[4,5]imidazo[1,2-c]quinazoline-6-carbonitriles via Oxidative
and Nonoxidative C–N Couplings . J. Org.
Chem. 
2015 , 80 , 8329 –8340 . 10.1021/acs.joc.5b01514 .26252396 
Shinde A. H. ; Arepally S. ; Baravkar M. D. ; Sharada D. S. 
Nickel-Catalyzed
Aerobic Oxidative Isocyanide Insertion: Access to Benzimidazoquinazoline
Derivatives via a Sequential Double Annulation Cascade (SDAC) Strategy . J. Org. Chem. 
2017 , 82 , 331 –342 . 10.1021/acs.joc.6b02423 .27936770 
a Ambethkar S. ; Padmini V. ; Bhuvanesh N. 
A green and
efficient protocol for the synthesis of dihydropyrano[2,3-c]pyrazole
derivatives via a one-pot, four component reaction by grinding method . J. Adv. Res. 
2015 , 6 , 975 –985 . 10.1016/j.jare.2014.11.011 .26644936  b Ambethkar S. ; Padmini V. ; Bhuvanesh N. 
A one-pot
sequential five-component domino reaction for the expedient synthesis
of polysubstituted pyrroles . New J. Chem. 
2016 , 40 , 4705 –4709 . 10.1039/C5NJ03444B . c Dhinakaran I. ; Padmini V. ; Bhuvanesh N. 
Chemodivergent,
One-Pot, Multi-Component Synthesis of Pyrroles and Tetrahydropyridines
under Solvent- and Catalyst-Free Conditions Using the Grinding Method . ACS Comb. Sci. 
2016 , 18 , 236 –242 . 10.1021/acscombsci.5b00154 .26972275  d Ambethkar S. ; Vellimalai M. ; Padmini V. ; Bhuvanesh N. 
Iodine-mediated
C–N and C–S bond formation: regioselective synthesis
of benzo[4,5]imidazo[2,1-b]thiazoles . New J.
Chem. 
2017 , 41 , 75 –80 . 10.1039/C6NJ02102F . e Kumar M. ; Sribalan R. ; Padmini V. 
Er(OTf)3 Assisted Efficient Synthesis of 3-Hydroxynaphthalene-1, 4-Dione
Derivatives via Pseudo Four-Component Reactions and Their Biological
Evaluation . ChemistrySelect 
2017 , 2 , 489 –49 . 10.1002/slct.201601340 . f Ambethkar S. ; Kalaiselvi M. ; Padmini V. ; Bhuvanesh N. 
Synthesis
of 3-Substituted Quinazolinones via C-N and C–C bond Cleavage
of Enaminone . ChemistrySelect 
2017 , 2 , 5329 –5332 . 10.1002/slct.201700457 .

